Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kostas K Tsilidis

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of the American Academy of Dermatology|November 28, 2022
Response to comment on "Psoriasis and COVID-19: A bidirectional Mendelian randomization study"Christos V Chalitsios, Kostas K Tsilidis, Ioanna Tzoulaki
Journal of the American Academy of Dermatology|October 16, 2022
Psoriasis and COVID-19: A bidirectional Mendelian randomization studyChristos V Chalitsios, Kostas K Tsilidis, Ioanna Tzoulaki
Journal of the American Academy of Dermatology|November 12, 2022
Investigating modifiable pathways in psoriasis: A Mendelian randomization studyChristos V Chalitsios, Andrea Georgiou, Emmanouil Bouras, et al.
International Journal of Cancer|November 3, 2018
Risk factors for endometrial cancer: An umbrella review of the literatureOlivia Raglan, Ilkka Kalliala, Georgios Markozannes, et al.
Nature Communications|March 13, 2025
GWAS identifies genetic loci, lifestyle factors and circulating biomarkers that are risk factors for sarcoidosisShuai Yuan, Jie Chen, Jiawei Geng, et al.
Diabetologia|May 12, 2023
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysisJames Yarmolinsky, Emmanouil Bouras, Andrei Constantinescu, et al.
BMC Medicine|January 4, 2023
Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization studyNikos Papadimitriou, Caroline J Bull, Mazda Jenab, et al.
Cancers|December 17, 2024
Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC StudyEnrique Almanza-Aguilera, Miriam Martínez-Huélamo, Yamilé López-Hernández, et al.
Journal of the National Cancer Institute|June 13, 2025
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer preventionJames Yarmolinsky, Matthew A Lee, Evelyn Lau, et al.
International Journal of Epidemiology|April 8, 2024
Design and quality control of large-scale two-sample Mendelian randomization studiesPhilip C Haycock, Maria Carolina Borges, Kimberley Burrows, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of the American Academy of Dermatology|November 28, 2022
Response to comment on "Psoriasis and COVID-19: A bidirectional Mendelian randomization study"Christos V Chalitsios, Kostas K Tsilidis, Ioanna Tzoulaki
Journal of the American Academy of Dermatology|October 16, 2022
Psoriasis and COVID-19: A bidirectional Mendelian randomization studyChristos V Chalitsios, Kostas K Tsilidis, Ioanna Tzoulaki
Journal of the American Academy of Dermatology|November 12, 2022
Investigating modifiable pathways in psoriasis: A Mendelian randomization studyChristos V Chalitsios, Andrea Georgiou, Emmanouil Bouras, et al.
International Journal of Cancer|November 3, 2018
Risk factors for endometrial cancer: An umbrella review of the literatureOlivia Raglan, Ilkka Kalliala, Georgios Markozannes, et al.
Nature Communications|March 13, 2025
GWAS identifies genetic loci, lifestyle factors and circulating biomarkers that are risk factors for sarcoidosisShuai Yuan, Jie Chen, Jiawei Geng, et al.
Diabetologia|May 12, 2023
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysisJames Yarmolinsky, Emmanouil Bouras, Andrei Constantinescu, et al.
BMC Medicine|January 4, 2023
Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization studyNikos Papadimitriou, Caroline J Bull, Mazda Jenab, et al.
Cancers|December 17, 2024
Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC StudyEnrique Almanza-Aguilera, Miriam Martínez-Huélamo, Yamilé López-Hernández, et al.
Journal of the National Cancer Institute|June 13, 2025
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer preventionJames Yarmolinsky, Matthew A Lee, Evelyn Lau, et al.
International Journal of Epidemiology|April 8, 2024
Design and quality control of large-scale two-sample Mendelian randomization studiesPhilip C Haycock, Maria Carolina Borges, Kimberley Burrows, et al.
Pageof 3